# Grace Therapeutics, Inc.: Form 8-K, filed Aug 27, 2021

- Company: [Grace Therapeutics, Inc.](/companies/grce.md) (CIK 1444192)
- Form: 8-K
- Filed: 2021-08-27
- Accepted by EDGAR: Aug 27, 2021, 08:47 ET
- Period: 2021-08-26
- Accession: 0001171843-21-006192
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1444192/000117184321006192/f8k_082721.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1444192/000117184321006192/

## Items reported

- Item 2.01: Completion of an acquisition or disposition
- Item 3.03: Change to security holders’ rights
- Item 5.02: Departure or appointment of officers or directors
- Item 5.03: Amendment to articles or bylaws
- Item 5.07: Shareholder vote results
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1444192/000117184321006192/f8k_082721.htm

Filed Aug 27, 2021.
Source: SEC EDGAR, the filing index for accession 0001171843-21-006192. Last ingested by Listed: Nov 14, 2026, 23:10 ET. No prices; not investment advice.
